How much they sold
About 4.8m
Operating income / revenue in 2025.
Simple version
Explain it like I’m ten
Numbers from the 2025 accounts. [R2025]
Did they make money?
4.2m
Net result for 2025.
What’s left in the company
Equity 661.7k
Book equity at year-end.
Cash
359.3k
Bank deposits and cash (when disclosed).
At a glance · 2025
Key figures
Revenue / sales
4 800 401
NOK · [R2025]
Net result
4 232 907
NOK · [R2025]
Equity
661 686
NOK · [R2025]
Cash
359 311
NOK · [R2025]
Total assets
1 776 106
NOK · [R2025]
Paid-in equity
60 000
NOK · [R2025]
Trends
4-year arc
Charts use figures extracted from published annual reports.
Sales / revenue
Equity & cash
Cost / investment lines
Salary costs (lønnskostnader)
FTEs (årsverk)
From notes when disclosed; blank years mean not found in OCR.
Analyst briefing
Company read — signals, board & numbers
Auto-written from filings, Brreg kunngjøringer, board timeline, address history, and the signal board. Interpretive — not investment advice.
Year by year
Comparing consecutive annual reports
Each filing pair has a dedicated, crawlable article page. Below is a preview of the latest comparison.
Executive summary
Auto-generated from filings
AD FONTE KLINIKKEN AS · 4 published annual accounts (2022–2025). Latest year revenue 4.8m NOK, net result 4.2m NOK, equity 661.7k NOK, cash 359.3k NOK. Figures from Brønnøysund årsregnskapskopi / nøkkeltall. Interpretation
What improved
Vs prior year
What deteriorated
Vs prior year
No clear deteriorations vs prior year on the core lines.
Buyer profile
What they may buy next
Sales-oriented read of industry, stage, filings, and registry signals — what this company is likely to purchase or hire over the next year. Interpretive, not a stated budget.
Health metrics
Ratios from the accounts
Source citations
Every material claim traces here
- [R2022] Årsregnskap 2022 · journal 2023 312984 · approved 24.01.2023 · registry 27.02.2023
- [R2023] Årsregnskap 2023 · journal 2024 546804 · approved 13.02.2024 · registry 26.06.2024
- [R2024] Årsregnskap 2024 · journal 2025 375603 · approved 08.04.2025 · registry 14.04.2025
- [R2025] Årsregnskap 2025 · journal 2026 336409 · approved 04.03.2026 · registry 14.03.2026
Original annual reports
Source documents
Årsregnskap 2025
Approved 04.03.2026
Fee deadline 31.07.2026
Registry 14.03.2026
On time vs fee deadline
Årsregnskap 2024
Approved 08.04.2025
Fee deadline 31.07.2025
Registry 14.04.2025
On time vs fee deadline
Årsregnskap 2023
Approved 13.02.2024
Fee deadline 31.07.2024
Registry 26.06.2024
On time vs fee deadline
Årsregnskap 2022
Approved 24.01.2023
Fee deadline 31.07.2023
Registry 27.02.2023
On time vs fee deadline
Signals
Hard · medium · soft
Derived from published accounts, Brreg roles, and kunngjøringer. Soft signals are interpretive — not facts or buying proof.
Registered address
Where the company sat over time
From Brreg «Endring av forretningsadresse» filings. Hubs and c/o addresses are tagged so you can see the path from incubator to own office.
Board & management
Who joined and left
Diffed from Styre / Daglig leder kunngjøringer (full public history).
Løsøreregisteret
Heftelser & rettsstiftelser
Active pant / utlegg and other registrations from Brreg’s public rettsstiftelser oppslag (not a full credit report).
Kunngjøringer
Full registry history
Ownership
Owners, officers & filing notes
Prefer Skatteetaten’s Aksjonærregisteret when available. Otherwise FirmaIQ shows Brreg officers (name + birth date) and any shareholder names disclosed in the annual-report «Aksjeeiere» note.